Derek Miller

Derek Miller currently serves as the Chief Executive Officer of Vellum Biosciences and holds the position of Director on the Board of Zymeworks Inc., where Derek chairs the Nomination and Governance Committee and is a member of the Audit Committee. Additionally, Derek Miller is the Principal Consultant at Derek J Miller Consulting, LLC, and a Trustee at The Leukemia & Lymphoma Society's Eastern PA Chapter. Previously, Derek Miller was the Chief Business Officer and Head of Corporate Strategy at Aro Biotherapeutics, Chief Business Officer at Celator Pharmaceuticals, and held leadership roles at Genentech, including National Director of Field Reimbursement and Director of Marketing. Earlier in the career, Derek Miller also worked at Centocor and GlaxoSmithKline Pharmaceuticals. Educational qualifications include an MBA in Marketing from Villanova University and a BA in Biology from the University of Delaware.